AI assistant
Sending…
Dare Bioscience, Inc. — Director's Dealing 2021
Apr 20, 2021
34825_dirs_2021-04-20_70fde200-4654-4636-8412-9f129738cc52.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2021-04-16
Reporting Person: Ononye-Onyia Sophia Nnenna (Director)
More from Dare Bioscience, Inc.
Proxy Solicitation & Information Statement
2026
Jun 1
Proxy Solicitation & Information Statement
2026
Jun 1
Capital/Financing Update
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Apr 22
Board/Management Information
2026
Apr 17
Capital/Financing Update
2026
Apr 13